Your session is about to expire
← Back to Search
Neurostimulation
Electrophysiology assessment - corticospinal tract for Spinal Cord Injury
N/A
Waitlist Available
Led By Ismael Seanez, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes before and 30 minutes into intervention
Awards & highlights
Study Summary
This trial will test if re-enabling movement of paralyzed areas is possible using transcutaneous spinal cord stimulation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 minutes before and 30 minutes into intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes before and 30 minutes into intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in corticospinal tract excitability after training
Changes in reticulospinal tract excitability after training
Trial Design
2Treatment groups
Experimental Treatment
Group I: Reaction time evaluation during non-invasive spinal cord stimulation and leg movementsExperimental Treatment2 Interventions
This arm will receive the loud auditory stimuli to evaluate the excitability of the reticulospinal tract first then the arm will receive the transcranial magnetic stimulation to excite the corticospinal tract second
Group II: Evaluation of motor evoked potentials during non-invasive spinal cord stimulation and leg movementsExperimental Treatment2 Interventions
This arm will receive the transcranial magnetic stimulation to evaluate the excitability of the corticospinal tract first then the arm will receive the loud auditory stimuli to evaluate the excitability of the reticulospinal track second.
Find a Location
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
1,945 Previous Clinical Trials
2,303,800 Total Patients Enrolled
Ismael Seanez, PhDPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
120 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger